These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Bortezomib suppresses function and survival of plasmacytoid dendritic cells by targeting intracellular trafficking of Toll-like receptors and endoplasmic reticulum homeostasis. Hirai M; Kadowaki N; Kitawaki T; Fujita H; Takaori-Kondo A; Fukui R; Miyake K; Maeda T; Kamihira S; Miyachi Y; Uchiyama T Blood; 2011 Jan; 117(2):500-9. PubMed ID: 20956804 [TBL] [Abstract][Full Text] [Related]
9. Pathway analysis of global gene expression change in dendritic cells induced by the polysaccharide from the roots of Actinidia eriantha. Du J; Chen X; Wang C; Sun H J Ethnopharmacol; 2018 Mar; 214():141-152. PubMed ID: 29247698 [TBL] [Abstract][Full Text] [Related]
10. Effect of novel proteasome and immunoproteasome inhibitors on dendritic cell maturation, function, and expression of IκB and NFκB. Al-Homsi AS; Lai Z; Roy TS; Kouttab N Transpl Immunol; 2013 Dec; 29(1-4):1-6. PubMed ID: 24103732 [TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition suppresses essential immune functions of human CD4+ T cells. Berges C; Haberstock H; Fuchs D; Miltz M; Sadeghi M; Opelz G; Daniel V; Naujokat C Immunology; 2008 Jun; 124(2):234-46. PubMed ID: 18217957 [TBL] [Abstract][Full Text] [Related]
12. Proteasomal chymotrypsin-like peptidase activity is required for essential functions of human monocyte-derived dendritic cells. Naujokat C; Berges C; Höh A; Wieczorek H; Fuchs D; Ovens J; Miltz M; Sadeghi M; Opelz G; Daniel V Immunology; 2007 Jan; 120(1):120-32. PubMed ID: 17083604 [TBL] [Abstract][Full Text] [Related]
13. Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). Arpinati M; Chirumbolo G; Nicolini B; Agostinelli C; Rondelli D Bone Marrow Transplant; 2009 Feb; 43(3):253-9. PubMed ID: 18806836 [TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor promotes TLR4 signaling-induced maturation of human dendritic cells in vitro through inducible p75NTR 1. Jiang Y; Chen G; Zhang Y; Lu L; Liu S; Cao X J Immunol; 2007 Nov; 179(9):6297-304. PubMed ID: 17947706 [TBL] [Abstract][Full Text] [Related]
15. Maximal apoptosis of renal cell carcinoma by the proteasome inhibitor bortezomib is nuclear factor-kappaB dependent. An J; Sun Y; Fisher M; Rettig MB Mol Cancer Ther; 2004 Jun; 3(6):727-36. PubMed ID: 15210859 [TBL] [Abstract][Full Text] [Related]
17. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902 [TBL] [Abstract][Full Text] [Related]
18. Immunosensitization of tumor cells to dendritic cell-activated immune responses with the proteasome inhibitor bortezomib (PS-341, Velcade). Schumacher LY; Vo DD; Garban HJ; Comin-Anduix B; Owens SK; Dissette VB; Glaspy JA; McBride WH; Bonavida B; Economou JS; Ribas A J Immunol; 2006 Apr; 176(8):4757-65. PubMed ID: 16585569 [TBL] [Abstract][Full Text] [Related]
19. The proteasome inhibitor bortezomib inhibits the release of NFkappaB-inducible cytokines and induces apoptosis of activated T cells from rheumatoid arthritis patients. van der Heijden JW; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G Clin Exp Rheumatol; 2009; 27(1):92-8. PubMed ID: 19327235 [TBL] [Abstract][Full Text] [Related]
20. Saucerneol D inhibits dendritic cell activation by inducing heme oxygenase-1, but not by directly inhibiting toll-like receptor 4 signaling. Ryu HS; Lee HK; Kim JS; Kim YG; Pyo M; Yun J; Hwang BY; Hong JT; Kim Y; Han SB J Ethnopharmacol; 2015 May; 166():92-101. PubMed ID: 25792017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]